MedTrace Logo

Early Detection of Advanced Fatty Liver Disease

NCT03608748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-02-29

No results posted yet for this study

Summary

Non-alcoholic fatty liver disease is the most common cause of chronic liver disease in the western world, affecting one in every three subjects.

The investigators hypothesize that a patient population without known liver disease has a certain percentage of patients with liver fibrosis who are undiagnosed and not monitored.

Conditions

  • Non-alcoholic Fatty Liver Disease
  • Liver Fibrosis

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    lead OTHER

Principal Investigators

  • Rawi Hazzan, Dr · haemek medical center

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2022-12-31
Completion
2023-03-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03608748 on ClinicalTrials.gov